Attovia Therapeutics files for IPO on Nasdaq

Attovia Therapeutics, Inc. has filed for an initial public offering of common stock, according to a press release statement. The company plans to list its shares on the Nasdaq Global Market under the ticker symbol ATTO, pending exchange approval.

The number of shares being offered and the price range have not been specified in the filing. Morgan Stanley, Leerink Partners, Citigroup, and RBC Capital Markets are serving as underwriters for the offering.

Prior to this offering, there has been no public market for Attovia Therapeutics common stock.

You May Also Be Interested In

• Csquare prices IPO at $21 per share, raising $1.01 billion
• Cadrenal Therapeutics CMO resigns, separation terms disclosed
• DBV Technologies refreshes ATM program with $150M ADS offering